Incidence Rates of Four Major Non-Communicable Chronic Diseases in the Chinese Adult Population from 2007 to 2016: A Study Based on a National Commercial Claims Database

References

• World Health Organization. Noncommunicable Diseases. Geneva: World Health Organization; 2018 Available from: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. Accessed 19, 2020.
   Google Scholar
• Hunter DJ, Reddy KS. Noncommunicable diseases. N Engl J Med. 2013;369(14):1336–1343. doi:10.1056/NEJMra110934524088093
   PubMed Web of Science ®Google Scholar
• World Health Organization. Noncommunicable Diseases Country Profiles 2018. Geneva: World Health Organization; 2018 Available from: https://www.who.int/nmh/publications/ncd-profiles-2018/en. Accessed 19, 2020.
   Google Scholar
• Min Y, Jiang L-X, Yan L-JL, et al. Tackling China’s noncommunicable diseases: shared origins, costly consequences and the need for action. Chin Med J. 2015;128(6):839–843. doi:10.4103/0366-6999.15269025758283
   PubMed Web of Science ®Google Scholar
• Kroll M, Phalkey RK, Kraas F. Challenges to the surveillance of non-communicable diseases–a review of selected approaches. BMC Public Health. 2015;15:1243. doi:10.1186/s12889-015-2570-z26672992
   PubMed Web of Science ®Google Scholar
• Benziger CP, Roth GA, Moran AE. The Global Burden of Disease Study and the preventable burden of NCD. Glob Heart. 2016;11(4):393–397. doi:10.1016/j.gheart.2016.10.02427938824
   PubMed Web of Science ®Google Scholar
• Sherman RE, Anderson SA, Dal Pan GJ, et al. Real-world evidence — what is it and what can it tell us? N Engl J Med. 2016;375(23):2293–2297. doi:10.1056/NEJMsb160921627959688
   PubMed Web of Science ®Google Scholar
• Marten R, McIntyre D, Travassos C, et al. An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS). Lancet. 2014;384(9960):2164–2171. doi:10.1016/S0140-6736(14)60075-124793339
   PubMed Web of Science ®Google Scholar
• Feng PC. Current status and prospects of critical illness insurance products. China Med Insurance. 2014;9:62–65.
   Google Scholar
• Definition of disease in critical illness insurance. Available from: http://www.awi-intl.com/life/disease/definitionofdisease.pdf. Accessed 19, 2020.
   Google Scholar
• Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJ, Lozano R, Inoue M. Age Standardization of Rates: a New WHO Standard (GPE Discussion Paper Series No. 31). Geneva: World Health Organization; 2001.
   Google Scholar
• Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z10649300
   PubMed Web of Science ®Google Scholar
• Institute NC. Version 4.6.0-April 2018. Bethesda, MD: Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institue; 2018 Available from: https://surveillance.cancer.gov/joinpoint. Accessed 19, 2020.
   Google Scholar
• Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322. doi:10.1001/jamaoto.2014.124557566
   PubMed Web of Science ®Google Scholar
• Colonna M, Grosclaude P, Remontet L, et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Eur J Cancer. 2002;38(13):1762–1768. doi:10.1016/S0959-8049(02)00110-712175693
   PubMed Web of Science ®Google Scholar
• Kilfoy BA, Zheng T, Holford TR, et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control. 2009;20(5):525–531. doi:10.1007/s10552-008-9260-419016336
   PubMed Web of Science ®Google Scholar
• Roman BR, Morris LG, Davies L. The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes. 2017;24(5):332–336. doi:10.1097/MED.000000000000035928692457
   PubMedGoogle Scholar
• Chen W, Sun K, Zheng R, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1–12. doi:10.21147/j.issn.1000-9604.2018.01.0129545714
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.v68.630207593
   PubMed Web of Science ®Google Scholar
• Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013;23(7):885–891. doi:10.1089/thy.2013.004523517343
   PubMed Web of Science ®Google Scholar
• Esserman LJ, Thompson IM Jr, Reid B. Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA. 2013;310(8):797–798. doi:10.1001/jama.2013.10841523896967
   PubMed Web of Science ®Google Scholar
• Wang W, Jiang B, Sun H, et al. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759–771. doi:10.1161/CIRCULATIONAHA.116.02525028052979
   PubMed Web of Science ®Google Scholar
• Guan T, Ma J, Li M, et al. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013. Neurology. 2017;89(1):53–61. doi:10.1212/WNL.000000000000405628566547
   PubMed Web of Science ®Google Scholar
• Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6(5):456–464. doi:10.1016/S1474-4422(07)70004-217434100
   PubMed Web of Science ®Google Scholar
• Grotto I, Huerta M, Grossman E, Sharabi Y. Relative impact of socioeconomic status on blood pressure lessons from a large-scale survey of young adults. Am J Hypertens. 2007;20(11):1140–1145. doi:10.1016/j.amjhyper.2007.06.00417954358
   PubMed Web of Science ®Google Scholar
• Addo J, Ayerbe L, Mohan KM, et al. Socioeconomic status and stroke: an updated review. Stroke. 2012;43(4):1186–1191. doi:10.1161/STROKEAHA.111.63973222363052
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-925777665
   PubMed Web of Science ®Google Scholar
• Gan L, Zuo L. Current ESRD burden and its future trend in Beijing, China. Clin Nephrol. 2015;83(7 Suppl 1):17–20. doi:10.5414/CNP83S01725725236
   PubMed Web of Science ®Google Scholar
• Zhang WM. Current status of dialysis therapy in Shanghai (results from Shanghai Renal Registry, 2011). Chin J Blood Purifi. 2012;11(5):233–236.
   Google Scholar
• Sun L, Zou LX, Han YC, et al. Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025. BMC Nephrol. 2016;17(1):60. doi:10.1186/s12882-016-0269-827295981
   PubMed Web of Science ®Google Scholar
• Association TR. UK renal registry: 20th annual report 2017. Available from: https://www.renalreg.org/wp-content/uploads/2018/06/20th-Annual-Report_web_book.pdf. Accessed 19, 2020.
   Google Scholar
• Registry A. The 40th annual ANZDATA report 2017. http://www.anzdata.org.au/v1/report_2017.html. Accessed 19, 2020.
   Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3s1):A7. doi:10.1053/j.ajkd.2018.01.00229477157
   PubMed Web of Science ®Google Scholar
• Huang YM, Xu D, Long J, et al. Spectrum of chronic kidney disease in China: a national study based on hospitalized patients from 2010 to 2015. Nephrology. 2019;24:725–736. doi:10.1111/nep.1348930198082
   PubMed Web of Science ®Google Scholar
• Li D, Lv J, Liu F, et al. Hypertension burden and control in mainland China: analysis of nationwide data 2003–2012. Int J Cardiol. 2015;184:637–644. doi:10.1016/j.ijcard.2015.03.04525771229
   PubMed Web of Science ®Google Scholar
• Zhou X, Guan H, Zheng L, et al. Prevalence and awareness of diabetes mellitus among a rural population in China: results from Liaoning Province. Diabet Med. 2015;32(3):332–342. doi:10.1111/dme.1259925308779
   PubMed Web of Science ®Google Scholar
• Yang L, Shao J, Bian Y, et al. Prevalence of type 2 diabetes mellitus among inland residents in China (2000–2014): a meta-analysis. J Diabetes Investig. 2016;7(6):845–852. doi:10.1111/jdi.2016.7.issue-6
   PubMed Web of Science ®Google Scholar